Company · CIK 0001160308 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Savara Inc · SVRA
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 24, 2026 FForm 4 → | Sep 25, 7:01 pm EDT | Braden C. ParkerChief Commercial Officer | 29,323 | $5.07 | $148,668 | 75,677 | — | |
| Jul 15, 2026 AForm 4 → | Jul 24, 6:24 pm EDT | Robert Matthew LutzChief Fin. & Operating Officer | 35,000 | — | — | 328,977 | — | late |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 15, 2026 AForm 4 → | Jul 24, 6:24 pm EDT | Robert Matthew LutzChief Fin. & Operating Officer | 70,000 | — | — | 70,000 | — | late |